Michael D. Clayman, President and CEO at Flexion Therapeutics Inc (FLXN), bought 8,092 shares at $12.36 ($100K) on 2019-03-12, disclosed to the SEC on 2019-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.36 | 4,046 | $50K | 50.0% |
| 2 | $12.36 | 4,046 | $50K | 50.0% |
| Total | $12.36 avg | 8,092 | $100K | 100% |
| Filing → |
| FLXN | BUY | 2019-05-13 | $100K | — | Filing → |
| FLXN | SELL | 2019-01-04 | $41K | — | Filing → |
| FLXN | BUY | 2018-11-13 | $86K | — | Filing → |